ZeClinics to Showcase Innovative Neurotoxicity Assessment Methods at DNT5 Conference.

ZeClinics participation in DNT5 2024

ZeClinics is thrilled to announce our attendance at the 5th International Conference on Developmental Neurotoxicity Testing (DNT5), happening from April 7th to 10th, 2024, in Konstanz, Germany.

At DNT5, we'll engage in symposia, workshops, and keynote sessions alongside leading experts in the developmental neurotoxicity field. Topics will include understanding human disease mechanisms, implementing novel approach methods, linking epidemiology to testing and regulations, exploring novel screening strategies, and refining regulatory and risk assessment approaches.

Claudia Miguel will be presenting the poster titled 'Embryonic Zebrafish Light/Dark Transition Test for Developmental Neurotoxicity Assessment of Widely Used Pharmaceutical Compounds.'

Join us as we collaborate with global stakeholders including research scientists, regulators, industry representatives, academics, and pediatricians to advance the development of time-efficient and human-relevant predictive in vitro DNT methods. Together, we'll propel these methods towards enhanced utilization in risk assessment and regulatory decision-making.

Don't miss this opportunity to connect with us and contribute to the future of neurotoxicity testing. See you at DNT5!

 

ZeClinics' participants:

Valentina Schiavone, Quality Manager

Claudia Miguel, Market Access Specialist

 

Are you planning to attend the Conference?

Contact us to arrange a personal meeting

Contact Us

    Meet our scientific advisors and get your project started now.

    * Mandatory field

    * Mandatory field

    * Mandatory field

    * Mandatory field

    * Mandatory field

    * Mandatory field

    * Mandatory field
    * Mandatory field
    Captcha erróneo